-
Medications Activating sGC Protein May Have Promise as SCD Therapy
Medications that activate the protein soluble guanylyl cyclase (sGC) may have promise as a treatment for sickle cell disease (SCD), an early study suggests. Read more here.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.